OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
600378$39.2559

600378.SS

Commodity ChemicalsVerified

The company maintains a market price of 39.25 CNY, with a market capitalization of 50.63 billion CNY. Its price-to-earnings ratio is 35.05, and the price-to-book ratio is 2.78, indicating a relatively high valuation compared to its book value. The company's return on equity is 7.93%, and its return on assets is 4.55%, which are key indicators of its profitability and efficiency in utilizing its assets. The company's capital structure is characterized by a debt-to-equity ratio of 0.26, suggesting a relatively low level of leverage. The current ratio of 1.5 indicates that the company has sufficient current assets to cover its current liabilities, which is a positive sign for its short-term liquidity. However, the risk assessment highlights a medium liquidity risk, with a note that net cash is negative after subtracting total debt, indicating potential liquidity constraints. The company's operating income is 1.91 billion CNY, and its net income is 1.44 billion CNY, reflecting a healthy profitability. The gross profit of 4.01 billion CNY suggests that the company is effectively managing its production costs. The operating cash flow of 1.92 billion CNY and free cash flow of 838.29 million CNY indicate strong cash generation capabilities. The company's capital expenditure is -1.52 billion CNY, which may indicate a reduction in capital spending or a reclassification of expenses. This could be a strategic move to preserve cash or a reflection of the company's current operational priorities. The company's liquidity position is further supported by its total assets of 31.73 billion CNY and total liabilities of 13.52 billion CNY, with total equity of 18.21 billion CNY. The company's revenue is 16.69 billion CNY, and its revenue concentration is not specified in the provided data. However, the company's exposure to different geographic regions and segments is not detailed, which may affect its risk profile and growth potential. The company's growth trajectory is not explicitly outlined, but the analyst estimates suggest a positive outlook, with a mean price target of 41.37 CNY and a median price target of 41.37 CNY. The company's risk assessment indicates a low dilution risk, which is a positive factor for shareholders. The company's liquidity risk is medium, and the key flag of negative net cash after subtracting total debt suggests that the company may need to manage its cash flow carefully to maintain its liquidity position. The company's recent events, such as filings and transcripts, are not detailed in the provided data, but the analyst estimates and recommendations provide some insight into the market's perception of the company.

30-day price · 600378+7.77 (+23.8%)
Low$31.83High$42.94Close$40.38As of28 May, 00:00 UTC
Profile
Company600378.SS
Ticker600378.SS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods.

Classification. The company is classified under the Basic Materials economic sector, within the Chemicals business sector, with a high confidence level of 0.92.

The company maintains a market price of 39.25 CNY, with a market capitalization of 50.63 billion CNY. Its price-to-earnings ratio is 35.05, and the price-to-book ratio is 2.78, indicating a relatively high valuation compared to its book value. The company's return on equity is 7.93%, and its return on assets is 4.55%, which are key indicators of its profitability and efficiency in utilizing its assets. The company's capital structure is characterized by a debt-to-equity ratio of 0.26, suggesting a relatively low level of leverage. The current ratio of 1.5 indicates that the company has sufficient current assets to cover its current liabilities, which is a positive sign for its short-term liquidity. However, the risk assessment highlights a medium liquidity risk, with a note that net cash is negative after subtracting total debt, indicating potential liquidity constraints. The company's operating income is 1.91 billion CNY, and its net income is 1.44 billion CNY, reflecting a healthy profitability. The gross profit of 4.01 billion CNY suggests that the company is effectively managing its production costs. The operating cash flow of 1.92 billion CNY and free cash flow of 838.29 million CNY indicate strong cash generation capabilities. The company's capital expenditure is -1.52 billion CNY, which may indicate a reduction in capital spending or a reclassification of expenses. This could be a strategic move to preserve cash or a reflection of the company's current operational priorities. The company's liquidity position is further supported by its total assets of 31.73 billion CNY and total liabilities of 13.52 billion CNY, with total equity of 18.21 billion CNY. The company's revenue is 16.69 billion CNY, and its revenue concentration is not specified in the provided data. However, the company's exposure to different geographic regions and segments is not detailed, which may affect its risk profile and growth potential. The company's growth trajectory is not explicitly outlined, but the analyst estimates suggest a positive outlook, with a mean price target of 41.37 CNY and a median price target of 41.37 CNY. The company's risk assessment indicates a low dilution risk, which is a positive factor for shareholders. The company's liquidity risk is medium, and the key flag of negative net cash after subtracting total debt suggests that the company may need to manage its cash flow carefully to maintain its liquidity position. The company's recent events, such as filings and transcripts, are not detailed in the provided data, but the analyst estimates and recommendations provide some insight into the market's perception of the company.
Key takeaways
  • The company has a high price-to-earnings ratio of 35.05, indicating a premium valuation.
  • The company's return on equity is 7.93%, which is a strong indicator of profitability.
  • The company's debt-to-equity ratio is 0.26, suggesting a relatively low level of leverage.
  • The company's liquidity risk is medium, with a note that net cash is negative after subtracting total debt.
  • The company's analyst estimates suggest a positive outlook, with a mean price target of 41.37 CNY.
  • # RATIONALES
  • **margin_outlook_rationale**: The company's gross profit margin is expected to remain stable due to consistent cost management.
  • **rd_outlook_rationale**: Research and development spending is expected to remain moderate as the company focuses on operational efficiency.
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$16.69B
Gross profit$4.01B
Operating income$1.91B
Net income$1.44B
R&D
SG&A
D&A
SBC
Operating cash flow$1.92B
CapEx-$1.52B
Free cash flow$838.3M
Total assets$31.73B
Total liabilities$13.52B
Total equity$18.21B
Cash & equivalents
Long-term debt$4.67B
Valuation
Market price$39.25
Market cap$50.63B
Enterprise value$55.30B
P/E35.0
Reported non-GAAP P/E
EV/Revenue3.3
EV/Op income28.9
EV/OCF28.8
P/B2.8
P/Tangible book2.8
Tangible book$18.21B
Net cash-$4.67B
Current ratio1.5
Debt/Equity0.3
ROA4.5%
ROE7.9%
Cash conversion1.3%
CapEx/Revenue-9.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
Metric600378Activity
Op margin11.4%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin8.7%4.1% medp25 0.1% · p75 8.8%above median
Gross margin24.1%20.5% medp25 12.4% · p75 29.7%above median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-9.1%-6.2% medp25 -13.4% · p75 -2.6%below median
Debt / equity26.0%37.1% medp25 10.3% · p75 82.0%below median
Observations
IR observations
Mean price target41.37 CNY
Median price target41.37 CNY
High price target45.36 CNY
Low price target37.38 CNY
Mean recommendation1.67 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count2.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate1.80 CNY
Last actual EPS1.12 CNY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-06 19:22 UTC#6e0971fd
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 00:16 UTCJob: 55d7189f